Logo Logo Logo Logo Logo
GNPX News

Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies

May 5, 2020
GNPX News

Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes

February 11, 2020
GNPX News

Genprex to Focus Its Clinical Efforts on Oncoprex™ in Combination Therapy with Osimertinib for Non-Small Cell Lung Cancer (NSCLC)

February 5, 2020
Hottest Stuff Now
Sorry, no posts matched your criteria.
FOLLOW US #QODETHEMES
QodeThemes
It seams that you haven't connected with your Twitter account
INSTAGRAM FEED
Sign Up & Get FREE News Alerts From FNM Today!
Sign Up

Terms of Service | Privacy Policy | Disclaimer

FinancialNewsMedia.com (FNM) is a third party publisher and news dissemination solutions provider of multimedia platforms that enable officers & directors, corporate communicators, public relations and investor relations officers to leverage content to engage with all their key audiences. Any ideas and opinions presented in any FNM News Alerts, Video clips, Press Releases, RSS Feeds or Social Network Posts are for informational purposes only, and do not reflect the opinions of FNM or any of its affiliates, subsidiaries or partners. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT CONTAINED HEREIN BE INTERPRETED TO REPRESENT TRADING OR INVESTMENT ADVICE. All viewers agree that under no circumstances will FNM, its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information contained on this or any affiliated website.
© 2020 Financial News Media. All Rights Reserved.